Robert Patrick Giugliano, M.D.
This page shows the publications co-authored by Robert Giugliano and Ik-Kyung Jang.
Adjunctive pharmacologic therapy in percutaneous coronary intervention: part I antiplatelet therapy. Coron Artery Dis. 2011 Mar; 22(1):100-12.
Adjunctive pharmacologic therapy in percutaneous coronary intervention: part II anticoagulant therapy. Coron Artery Dis. 2011 Mar; 22(1):113-21.
Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Am J Cardiol. 2000 Oct 01; 86(7):713-7.
A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study. J Am Coll Cardiol. 1999 Jun; 33(7):1879-85.
Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen Activator. J Thromb Thrombolysis. 1998 Sep; 6(2):103-108.
Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol. 2007 Dec 15; 100(12):1734-8.
A Randomized, Blinded Study of Two Doses of Novastan(R) (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan(R) and T-PA (MINT) Study. J Thromb Thrombolysis. 1998; 5(1):49-52.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.